BeOne Medicines Wins BIOHK 2025 Oncology Award for “1+” Cancer Platform

BeOne Medicines Wins BIOHK 2025 Oncology Award for “1+” Cancer Platform

Breakthrough “1+” model fast-tracks combo trials, cutting IND-to-Phase-I time 40 per cent and bagging the Global Oncology Innovation Leadership prize.